MedTrace Logo

The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction

NCT01207752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2025-04-01

Study results available
· View outcomes & findings →

Summary

The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.

Conditions

  • Meibomian Gland Dysfunction

Interventions

DRUG

Systane Balance

Artificial tear emulsion drop

DRUG

Optive Lubricant Eye Drops

Artificial tear eye drop

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Southern California College of Optometry at Marshall B. Ketchum University

    lead OTHER

Principal Investigators

  • Jerry R Paugh, OD, PhD · Southern California College of Optometry at Marshall B. Ketchum University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207752 on ClinicalTrials.gov